1. Home
  2. RANI vs INLX Comparison

RANI vs INLX Comparison

Compare RANI & INLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RANI
  • INLX
  • Stock Information
  • Founded
  • RANI 2012
  • INLX 1996
  • Country
  • RANI United States
  • INLX United States
  • Employees
  • RANI N/A
  • INLX 150
  • Industry
  • RANI Medicinal Chemicals and Botanical Products
  • INLX EDP Services
  • Sector
  • RANI Health Care
  • INLX Technology
  • Exchange
  • RANI Nasdaq
  • INLX Nasdaq
  • Market Cap
  • RANI 55.3M
  • INLX 60.5M
  • IPO Year
  • RANI 2021
  • INLX N/A
  • Fundamental
  • Price
  • RANI $1.23
  • INLX $14.21
  • Analyst Decision
  • RANI Strong Buy
  • INLX
  • Analyst Count
  • RANI 6
  • INLX 0
  • Target Price
  • RANI $11.33
  • INLX N/A
  • AVG Volume (30 Days)
  • RANI 145.5K
  • INLX 6.8K
  • Earning Date
  • RANI 03-31-2025
  • INLX 03-24-2025
  • Dividend Yield
  • RANI N/A
  • INLX N/A
  • EPS Growth
  • RANI N/A
  • INLX N/A
  • EPS
  • RANI N/A
  • INLX N/A
  • Revenue
  • RANI N/A
  • INLX $18,018,373.00
  • Revenue This Year
  • RANI N/A
  • INLX $8.12
  • Revenue Next Year
  • RANI N/A
  • INLX N/A
  • P/E Ratio
  • RANI N/A
  • INLX N/A
  • Revenue Growth
  • RANI N/A
  • INLX 6.70
  • 52 Week Low
  • RANI $1.20
  • INLX $5.85
  • 52 Week High
  • RANI $8.75
  • INLX $16.50
  • Technical
  • Relative Strength Index (RSI)
  • RANI 33.72
  • INLX 71.18
  • Support Level
  • RANI $1.30
  • INLX $11.70
  • Resistance Level
  • RANI $1.56
  • INLX $11.54
  • Average True Range (ATR)
  • RANI 0.09
  • INLX 0.54
  • MACD
  • RANI -0.03
  • INLX 0.30
  • Stochastic Oscillator
  • RANI 8.33
  • INLX 83.37

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads up to 200 microlitre in liquid form with high bioavailability.

About INLX Intellinetics Inc.

Intellinetics Inc is a document service and solutions software company serving both the small-to-medium business and governmental sectors. The company's digital transformation products and services are provided through two reporting segments: Document Management and Document Conversion. The Document Management segment consists of solutions involving software platforms, which allow customers to capture and manage all documents across operations such as scanned hard-copy documents and all digital documents including those from Microsoft Office 365, digital images, audio, video, and emails. The company's Document Conversion offerings aid clients as a part of their overall document to convert documents from one medium to another. Majority of revenue is from Document Conversion Segment.

Share on Social Networks: